News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-22 12:13:42 pm TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules GlobeNewsWire
2024-03-20 9:0:0 am TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules GlobeNewswire
2024-03-20 6:3:0 am TFF Pharmaceuticals Announces Update on Clinical Programs GlobeNewswire
2024-03-14 1:47:0 pm TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024 GlobeNewswire
2024-01-24 5:0:0 am TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference GlobeNewswire
2024-01-09 5:0:0 am TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information